Home > PE Ratio > LYKA LABS

LYKA LABS
PE (Price/Earnings) Ratio

The Current P/E Ratio of LYKA LABS is 177.82.

Share Price ₹155.8Jan 14,2025
Market Cap ₹556.0 Cr
Earnings-TTM₹3.1 CrTTM-Consolidated Results
Price/Earnings177.82xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results
LYKA LABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of LYKA LABS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of LYKA LABS is calculated as :

Current Market Cap [ ₹556.0 Cr] as on Jan 14,2025

(/) Earnings [ ₹3.1 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 177.82x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for LYKA LABS , the investors are currently willing to pay 177.82 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LYKA LABS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of LYKA LABS over the last five years.

Historical PE (Price/Earnings) ratio chart of LYKA LABS


PE Ratio Performance Analysis for LYKA LABS

- LYKA LABS 's latest p/e ratio is 177.82x.

- LYKA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.00x.

- LYKA LABS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2022 at 9.98x.

- LYKA LABS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does LYKA LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
LYKA LABS 3.13177.82556.0
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.11424,382.0
CIPLA LTD4,485.2226.07116,943.0
DR REDDYS LABORATORIES LTD5,406.8020.64111,588.0
ZYDUS LIFESCIENCES LTD4,298.9023.43100,704.0
DIVIS LABORATORIES LTD1,836.0086.72159,224.0
MANKIND PHARMA LTD2,124.8651.87110,215.0
TORRENT PHARMACEUTICALS LTD1,802.0061.12110,142.0
LUPIN LTD2,651.9437.0898,330.0
AUROBINDO PHARMA LTD3,598.8318.9668,238.4
ABBOTT INDIA LTD1,284.6646.7460,041.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LYKA LABS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.96x
Max industry PE 177.82x
Median industry PE 38.11x
Average industry PE 53.51x



You may also like the below Video Courses